Confirming the relevance of these findings to human TB patients, we found that iMtb-stimulated Mo-DCs from TB patients were deficient in their capacity to migrate toward CCL21 (Figure 6E) and in glycolytic activity compared to Mo-DCs from healthy subjects (Figure 6F and G). This evidence concerns the gene CCL21 and tuberculosis.